COVAXIN and Covishield granted regular market approval for use in adult population: Mansukh Mandaviya


COVAXIN and Covishield granted regular market approval for use in adult population: Mansukh Mandaviya The Drugs Controller General of India’s (DCGI) approval came after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on January 19 recommended granting regular market approval to the Serum Institute of India’s (SII’s) Covishield and Bharat Biotech’s Covaxin for use in adult population subject to certain conditions.